Cargando…

Effect of CD44st and HER2 expression on the postoperative prognosis of breast cancer patients

OBJECTIVE: CD44st is a member of the CD44 family; abnormal expression of some CD44 isoforms are closely associated with axillary lymph node metastasis, cancer progression, and patients’ prognosis. The objective of this study is to investigate the correlation between the expression of CD44st and HER2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Dan Dan, Ji, Jun An, Yan, Hai Cui, Huang, Guan Hong, Fang, Xin Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339464/ https://www.ncbi.nlm.nih.gov/pubmed/30697055 http://dx.doi.org/10.2147/OTT.S180972

Ejemplares similares

A correlation study of the expression of HA-CD44st and HER-2 in breast cancer
por: Ying Zhi, Lu, et al.
Publicado: (2018)

Negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cells and patient prognosis after breast cancer surgery
por: Jian, Fang Xin, et al.
Publicado: (2023)

CD44 Variant Isoform Expression and Breast Cancer Prognosis
por: Tokue, Yutaka, et al.
Publicado: (1998)

The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7
por: Fang, Xin Jian, et al.
Publicado: (2011)

Predictive Value of CD44 for Prognosis in Patients with Breast Cancer
por: Roosta, Yousef, et al.
Publicado: (2020)

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
por: Inoue, Kazushi, et al.
Publicado: (2015)

CD44, IL-33, and ST2 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility in the Chinese Population
por: Pan, Xiaolan, et al.
Publicado: (2020)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

CD44 expression in curettage and postoperative specimens of endometrial cancer
por: Wojciechowski, Michał, et al.
Publicado: (2014)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer
por: Li, Weiming, et al.
Publicado: (2017)

CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations
por: Jiang, Lan, et al.
Publicado: (2012)

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
por: Si, Daolin, et al.
Publicado: (2020)

Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas
por: Zhou, Dang-xia, et al.
Publicado: (2012)

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
por: Wu, Cheng-Lin, et al.
Publicado: (2015)

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
por: Cao, Xueyuan, et al.
Publicado: (2014)

CD44: A metastasis driver and therapeutic target
por: Sottnik, Joseph L., et al.
Publicado: (2016)

Correlation between tripartite motif-containing protein 44 protein expression and the prognosis of postoperative patients exhibiting skin squamous cell carcinoma
por: Wu, Jian, et al.
Publicado: (2018)

CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration
por: Zen, Ke, et al.
Publicado: (2008)

Increasing CD44(+)/CD24(- )tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis
por: Wang, Kai-Hung, et al.
Publicado: (2010)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

CD44 Gene Polymorphisms in Breast Cancer Risk and Prognosis: A Study in North Indian Population
por: Tulsyan, Sonam, et al.
Publicado: (2013)

Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45
por: Song, Xianghe, et al.
Publicado: (2016)

CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation
por: Guo, Qian, et al.
Publicado: (2021)

Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44
por: Zhao, Jiang-Sha, et al.
Publicado: (2011)

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.
por: Joensuu, H., et al.
Publicado: (1993)

Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019)

High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma
por: Louis-Brennetot, Caroline, et al.
Publicado: (2020)

Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis
por: Du, Zhanxin, et al.
Publicado: (2022)

Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo
por: Yang, Cuixia, et al.
Publicado: (2015)

Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
por: Shi, Hong-Zhi, et al.
Publicado: (2017)

Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer
por: Yamauchi, Teruo, et al.
Publicado: (2018)

CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism
por: Gao, Ruifang, et al.
Publicado: (2018)

CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis
por: Liu, Shuangqing, et al.
Publicado: (2023)

CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis
por: Wang, Ji-Lin, et al.
Publicado: (2016)

A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer
por: Liu, Dan, et al.
Publicado: (2015)

Metformin-induced preferential killing of breast cancer initiating CD44(+)CD24(−/low) cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
por: Cufí, Sílvia, et al.
Publicado: (2012)

FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis
por: Chen, Shinan, et al.
Publicado: (2018)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
por: Čēma, Ingrīda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mpbgh394e6j8t3it7haljpckp1